Statin use and pancreatic cancer risk in two prospective cohort studies

被引：0

作者：

Tsuyoshi Hamada

Natalia Khalaf

Chen Yuan

Ana Babic

Vicente Morales-Oyarvide

Zhi Rong Qian

Jonathan Andrew Nowak

Kimmie Ng

Peter Kraft

Douglas Adam Rubinson

Meir Jonathan Stampfer

Edward Luciano Giovannucci

Charles Stewart Fuchs

Shuji Ogino

Brian Matthew Wolpin

机构：

[1] Dana-Farber Cancer Institute and Harvard Medical School,Department of Oncologic Pathology

[2] Brigham and Women’s Hospital and Harvard Medical School,Division of Gastroenterology, Hepatology, and Endoscopy

[3] Dana-Farber Cancer Institute and Harvard Medical School,Department of Medical Oncology

[4] Harvard T.H. Chan School of Public Health,Department of Epidemiology

[5] Brigham and Women’s Hospital and Harvard Medical School,Program in MPE Molecular Pathological Epidemiology, Department of Patholog

[6] Harvard T.H. Chan School of Public Health,Department of Biostatistics

[7] Brigham and Women’s Hospital and Harvard Medical School,Channing Division of Network Medicine, Department of Medicine

[8] Harvard T.H. Chan School of Public Health,Department of Nutrition

[9] Yale Cancer Center,Department of Medicine

[10] Yale School of Medicine,undefined

[11] Smilow Cancer Hospital,undefined

来源：

Journal of Gastroenterology | 2018年 / 53卷

关键词：

Chemoprevention; Cohort studies; Hydroxymethylglutaryl-CoA reductase inhibitors; Pancreatic neoplasms; Risk factors;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：959 / 966

页数：7

共 106 条

[101]

Huang BZ(undefined)undefined undefined undefined undefined-undefined

[102]

Chang JI(undefined)undefined undefined undefined undefined-undefined

[103]

Li E(undefined)undefined undefined undefined undefined-undefined

[104]

Lee HS(undefined)undefined undefined undefined undefined-undefined

[105]

Lee SH(undefined)undefined undefined undefined undefined-undefined

[106]

Lee HJ(undefined)undefined undefined undefined undefined-undefined

← 2 3 4 5 6 7 8 9 10 11 →